Manuel Rodríguez

7PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Translation and interpretation studiesPredictive and prognostic markersMedical biochemistry - lipidsPacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 29, 2025
Challenges of using bevacizumab for hepatocellular carcinoma: incidence of adverse effects and mitigation strategies.

Marta García-Calonge, Andrés Castaño-García, Ana María Piedra Cerezal

|Jul 30, 2025
The role of immigration in chronic hepatitis B and C in Asturias - Origin and characteristics of the patients. An observational, cross-sectional study.

Ángela Suárez-Noya, Carmen Álvarez-Navascués, Mercedes Rodríguez

|Feb 19, 2025
Demographic and survival characteristics of untreated hepatocellular carcinoma patients: insights into the natural history and prognostic determinants.

Helena González-Sánchez, Andrés Castaño-García, Miriam Celada-Sendino

|Jan 20, 2025
Overlap autoimmune hepatitis and primary sclerosing cholangitis in a patient with multiple sclerosis.

Marta García Calonge, María García Martínez, Mateo García Ramos

|May 02, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns

|Apr 19, 2023
Macro-AST as a cause of hypertransaminasemia: an uncommon entity but it exists.

Miriam Celada-Sendino, Alejandra Fernández-Fernández, Manuel Rodríguez

Pageof 2

Frequent Collaborators

3 joint publications

Andrés Castaño-García

2 joint publications

Valentina Chiminazzo

2 joint publications

María Varela Calvo

2 joint publications

Marta García-Calonge